Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy
Lingfeng Zhang, Xinghuan Wang, Chenglu Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14029-14042
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Vicious Cycle‐Breaking Lipid Nanoparticles Remodeling Multicellular Crosstalk to Reverse Liver Fibrosis
Lingfeng Zhang, Wen‐Qi Deng, Qing‐Wen Huang, et al.
Advanced Materials (2024) Vol. 36, Iss. 16
Closed Access | Times Cited: 15
Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging
Wenya Li, Jing Lv, Honghui Li, et al.
Radiology (2025) Vol. 314, Iss. 1
Closed Access | Times Cited: 3
Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice
Meng‐Meng Han, Xing-Yue He, Tang Ling, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 38
Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis
Kaili Wang, Hao Chen, Jiani Zheng, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 219-232
Closed Access | Times Cited: 12
Dual Barrier‐Penetrating Inhaled Nanoparticles for Enhanced Idiopathic Pulmonary Fibrosis Therapy
Ming‐Yuan Yang, Meng‐Meng Han, Tang Ling, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 11
Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
Jie Liu, Jinhu Liu, Weiwei Mu, et al.
ACS Nano (2024) Vol. 18, Iss. 32, pp. 20861-20885
Closed Access | Times Cited: 11
Hyaluronic Acid Receptor‐Mediated Nanomedicines and Targeted Therapy
Qiuhong Ouyang, Ying Zhao, Kunyao Xu, et al.
Small Methods (2024)
Closed Access | Times Cited: 10
Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review)
Jiaqin Gao, Bin Zuo, Yang He
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 8
Reactive Oxygen Species‐Responsive Nanoparticles Toward Extracellular Matrix Normalization for Pancreatic Fibrosis Regression
Liang Qi, Bo‐Wen Duan, Hui Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 8
Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review
Xingtao Zhao, Felix Kwame Amevor, Xinyan Xue, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine
Han Han, Lei Xing, Bi‐Te Chen, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115051-115051
Closed Access | Times Cited: 16
Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling
Meng‐Meng Han, Tang Ling, Bin Huang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 732-745
Closed Access | Times Cited: 7
Targeted delivery strategies: The interactions and applications of nanoparticles in liver diseases
Xiandi Meng, Ge Zhu, Yong‐Guang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116702-116702
Open Access | Times Cited: 7
An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis
Bo‐Wen Duan, Yanjun Liu, Xue‐Na Li, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 14
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies
Wenhui Jia, Zhao Huang, Li Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100988-100988
Open Access | Times Cited: 13
Aggregation-Induced Emission CN-Based Nanoparticles to Alleviate Hypoxic Liver Fibrosis via Triggering HSC Ferroptosis and Enhancing Photodynamic Therapy
Mingxuan Liu, Yuting Cai, Ruojia Wang, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 26, pp. 33021-33037
Closed Access | Times Cited: 5
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
Qiongyao He, Wu He, Hui Dong, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Engineered MSCs Break Endothelial‐Myofibroblast Crosstalk in Pulmonary Fibrosis: Reconstructing the Vascular Niche
Yue‐Fei Fang, Chen Zhang, Meng‐Meng Han, et al.
Advanced Materials (2025)
Closed Access
Ultrasound‐Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis
Huan Deng, Huolin Ye, Hong Xiao, et al.
Advanced Healthcare Materials (2025)
Closed Access
Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis
Xia Niu, Yanan Meng, Jinjin Cui, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23608-23625
Closed Access | Times Cited: 11
Mitochondrial endogenous substance transport-inspired nanomaterials for mitochondria-targeted gene delivery
Yi Wang, Jingsong Yang, Min Zhao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115355-115355
Closed Access | Times Cited: 4
Liver cirrhosis: molecular mechanisms and therapeutic interventions
Zihe Dong, Yeying Wang, Weilin Jin
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Innovative nanomedicine approaches for the management of non-alcoholic fatty liver disease
Limeng Li, Weiqi Gao, Yao Feng, et al.
Journal of Controlled Release (2025), pp. 113680-113680
Closed Access
Sulfur dioxide-releasing nanomotors improve the therapeutic effect of liver fibrosis by restoring the fenestrae of sinusoids
Lin Chen, Zheng‐Wei Chen, Di Shi, et al.
Journal of Colloid and Interface Science (2025), pp. 137557-137557
Closed Access
A PDGFRβ-targeting nanodrill system for pancreatic fibrosis therapy
Han Han, Bi‐Te Chen, Jiarong Ding, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 10, pp. 109583-109583
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top